Substrate competitive inhibitors of IGF-1 receptor kinase
about
Crystal structure of the Apo, unactivated insulin-like growth factor-1 receptor kinase. Implication for inhibitor specificityFAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistanceDual targeting of insulin and venus kinase Receptors of Schistosoma mansoni for novel anti-schistosome therapyDevelopment of new insulin-like growth factor-1 receptor kinase inhibitors using catechol mimics.Adaptive potentiation in rod photoreceptors after light exposureInhibition of IGF-1 receptor kinase blocks the differentiation into cardiomyocyte-like cells of BMSCs induced by IGF-1Insulin and IGF receptor signalling in neural-stem-cell homeostasis.Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approachA Non-ATP-Competitive Dual Inhibitor of JAK2 and BCR-ABL Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition.Dystroglycan modulates the ability of insulin-like growth factor-1 to promote oligodendrocyte differentiation.Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assaysA homogeneous, high-throughput assay for phosphatidylinositol 5-phosphate 4-kinase with a novel, rapid substrate preparation.Identification of Novel IGF1R Kinase Inhibitors by Molecular Modeling and High-Throughput Screening.Small molecule substrate phosphorylation site inhibitors of protein kinases: approaches and challenges.δ-Opioid receptors stimulate GLUT1-mediated glucose uptake through Src- and IGF-1 receptor-dependent activation of PI3-kinase signalling in CHO cellsThe therapeutic potential of agents targeting the type I insulin-like growth factor receptor.Role of insulin-like growth factor 1 receptor signalling in cancer.Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signaling.Virtual screening of specific insulin-like growth factor 1 receptor (IGF1R) inhibitors from the National Cancer Institute (NCI) molecular databaseReactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.Measuring and interpreting the selectivity of protein kinase inhibitorsInsulin-like growth factor-II (IGF-II) and IGF-II analogs with enhanced insulin receptor-a binding affinity promote neural stem cell expansionInsulin-like growth factor-1 increases skeletal muscle dihydropyridine receptor alpha 1S transcriptional activity by acting on the cAMP-response element-binding protein element of the promoter region.Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes.Re-positioning protein-kinase inhibitors against schistosomiasis.Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells.Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activationNordihydroguaiaretic acid inhibits an activated fibroblast growth factor receptor 3 mutant and blocks downstream signaling in multiple myeloma cellsComparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitro.The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway.Insulin-like growth factor-1 receptor regulates repair of ultraviolet B-induced DNA damage in human keratinocytes in vivo.Nigella sativa Relieves the Altered Insulin Receptor Signaling in Streptozotocin-Induced Diabetic Rats Fed with a High-Fat Diet.The pp60c-Src inhibitor PP1 is non-competitive against ATP.Preservation of motor neuron Ca2+ channel sensitivity to insulin-like growth factor-1 in brain motor cortex from senescent rat.Readout technologies for highly miniaturized kinase assays applicable to high-throughput screening in a 1536-well format.
P2860
Q27639414-11325E11-1C57-4101-B4EE-59D0654DD846Q28077347-6F270696-5E14-4962-8ED9-7426E497C9D9Q28488169-1890E179-7C57-4382-AABA-27C33FBE5E43Q30812778-F757D245-4A7E-4D6F-AB07-76CD7C9ADB9CQ33672991-AB100B7C-10A1-43EB-BCB8-349E78A3277BQ33828282-A2CAE052-A717-4ABB-9450-1768D7DE0877Q33911127-F92DE3EE-C5C4-413A-8EAF-6B1DC318AEC3Q33925323-94468054-6FDC-41FC-A575-B3F0F9393B24Q34065882-C8D4EE9A-2A3F-4E04-8C45-B62828B4E204Q34192237-C358FE77-A5E8-4143-857F-4A2D355FFAFBQ34319607-D591EA28-9EA6-4471-9B1C-9D7433C5E369Q34552164-3C623CB7-7B25-4883-A3DF-324236DAC96FQ34789828-A440A3E9-F9BE-4AE1-A4E1-3DE9772349F2Q34992505-33CDC710-D3A0-424B-92ED-0003F4283F07Q35005700-B3293DB4-F183-4FFD-B34F-AFCB30F0CB56Q35964712-04D0EB05-52FB-4E8F-8B3D-01F5A5764234Q36163571-583C4946-B972-4A44-BDD8-6809FD005EE7Q36185627-51998866-9F4D-4303-A635-48B8A8ABC0EAQ36538579-19F96EA5-5E19-4BA4-8702-19CE2D39AF60Q37113552-68256190-FB6F-4DC3-BEC8-FE8268E15FCAQ37537075-0DDDFF2C-8C41-4938-BAF1-81B528E02B8AQ37596299-F5064168-B72E-4485-B309-0B0902A32A12Q38361469-6632EEFE-72E4-4127-A274-EEDD0772F6AEQ38410339-11B8AB23-1C23-4040-A80A-8575FB2EE43DQ38495042-554F29B5-A605-4B79-923E-F0C8E94219DDQ39553440-AF29DB9C-0DA6-4844-B3BB-39F554580A9BQ39640546-D43A08E3-5FF8-42D7-8989-037BA8EEF08FQ39939584-3DB8C54B-E1F7-432C-B69F-9099DA90947AQ40142014-298B3581-17EB-4AF3-A586-5555E2138EBCQ40521524-053A2976-75C3-4A8A-B4B1-8F7A324742A4Q41113979-239FCA73-CCA1-4DA2-8D92-605A6ECE3506Q41694546-4B276DEA-CB23-4282-A04A-14B05C5C7A91Q44328420-8B6CC2E4-0534-44E6-9E76-9711D43C237EQ44578387-66F15148-77C4-41D9-B393-6A6AA8DC8B6BQ54246015-A3A5923D-5ED3-41B6-B5E8-532AFB7BF273
P2860
Substrate competitive inhibitors of IGF-1 receptor kinase
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Substrate competitive inhibitors of IGF-1 receptor kinase
@ast
Substrate competitive inhibitors of IGF-1 receptor kinase
@en
Substrate competitive inhibitors of IGF-1 receptor kinase
@nl
type
label
Substrate competitive inhibitors of IGF-1 receptor kinase
@ast
Substrate competitive inhibitors of IGF-1 receptor kinase
@en
Substrate competitive inhibitors of IGF-1 receptor kinase
@nl
prefLabel
Substrate competitive inhibitors of IGF-1 receptor kinase
@ast
Substrate competitive inhibitors of IGF-1 receptor kinase
@en
Substrate competitive inhibitors of IGF-1 receptor kinase
@nl
P2093
P3181
P356
P1433
P1476
Substrate competitive inhibitors of IGF-1 receptor kinase
@en
P2093
P304
P3181
P356
10.1021/BI001516Y
P407
P577
2000-12-26T00:00:00Z